Test ID: FDS9R
Drug Screen 9 Panel, Serum or Plasma-Immunoassay Screen with Reflex to Mass Spectrometry Confirmation/Quantitation
NY State Approved 
Indicates the status of NY State approval and if the test is orderable for NY State clients.
Reflex Tests Lists test(s) that may or may not be performed, at an additional charge, depending on the result and interpretation of the initial test(s)
| Test ID | Reporting Name | Available Separately | Always Performed |
|---|---|---|---|
| FCANC | Cannabinoids, Confirmation | No | No |
| FCOMC | Cocaine and Metabolites, Confirm | No | No |
| FOPMC | Opiate and Metabolites Confirm | No | No |
| FPHNC | Phencyclidine, Confirmation | No | No |
| FAMPC | Amphetamines, Confirmation | No | No |
| FBABC | Barbiturates, Confirmation | No | No |
| FBENC | Benzodiazepines, Confirmation | No | No |
| FMMSP | Methadone and Metabolite Confirm | No | No |
| FPPMC | Propoxyphene/Metab, Confirmation | No | No |
Testing Algorithm Delineates situation(s) when tests are added to the initial order. This includes reflex and additional tests.
If screen is positive, specimens are automatically confirmed by GC/MS and/or LC/MS/MS at an additional charge.
Method Name A short description of the method used to perform the test
Qualitative Enzyme-Linked Immunosorbent Assay
Quantitative Gas Chromatography-Mass Spectrometry
Quantitative Liquid Chromatography-Tandem Mass Spectrometry
Reporting Name A shorter/abbreviated version of the Published Name for a test; an abbreviated test name
Aliases Lists additional common names for a test, as an aid in searching
DRUG SCRSP FORWARD
Drugs of Abuse 9 Panel FORWARD
Specimen Type Describes the specimen type needed for testing
Specimen Required Defines the optimal specimen. This field describes the type of specimen required to perform the test and the preferred volume to complete testing. The volume allows automated processing, fastest throughput and, when indicated, repeat or reflex testing.
Submit only one of the following:
Plasma
Draw blood in a gray top potassium oxalate/sodium fluoride, green (sodium heparin), lavender (EDTA), or pink (K2EDTA) tube(s). Spin down and send 4 mL of plasma refrigerate in a plastic vial.
Serum
Draw blood in a plain, red-top tube(s). Spin down and send 4 mL of serum refrigerate in a plastic vial.
Note: Cocaine and cocaethylene are more stable in fluoride-preserved plasma than serum.
Specimen Minimum Volume Defines the amount of specimen required to perform an assay once, including instrument and container dead space. Submitting the minimum specimen volume makes it impossible to repeat the test or perform confirmatory or perform reflex testing. In some situations, a minimum specimen volume may result in a QNS (quantity not sufficient) result, requiring a second specimen to be collected.
Reject Due To Identifies specimen types and conditions that may cause the specimen to be rejected
| Hemolysis: | NA |
| Thawing: | Warm OK; Cold OK |
| Lipemia: | NA |
| Icterus: | NA |
| Other: | Samples exposed to repeat freeze/thaw cycles, serum gel tubes, plasma gel tubes, plasma collected in lt blue sodium citrate, and whole blood are unacceptable. |
Specimen Stability Information Provides a description of the temperatures required to transport a specimen to the laboratory. Alternate acceptable temperature(s) are also included.
| Specimen Type | Temperature | Time |
|---|---|---|
| Varies | Refrigerated (preferred) | 14 days |
| Ambient | 7 days | |
| Frozen | ||
Reference Values Describes reference intervals and additional information for interpretation of test results. May include intervals based on age and sex when appropriate. Intervals are Mayo-derived, unless otherwise designated. If an interpretive report is provided, the reference value field will state this.
Interpretive Information: Drug Screen 9 Panel, Serum or Plasma – Immunoassay Screen with Reflex to Mass Spectrometry Confirmation/Quantitation
1. Methodology: Qualitative Immunoassay Screen
2. Drugs Covered and Cutoff Concentrations:
| Drugs/Drug Classes | Screen Cutoff |
| Amphetamines | 30 ng/mL |
| Methamphetamine | 30 ng/mL |
| Barbiturates | 75 ng/mL |
| Benzodiazepines | 75 ng/mL |
| Cannabinoids | 30 ng/mL |
| Cocaine | 30 ng/mL |
| Methadone | 40 ng/mL |
| Opiates | 30 ng/mL |
| Oxycodone | 30 ng/mL |
| Phencyclidine | 15 ng/mL |
| Propoxyphene | 75 ng/mL |
3. Drugs/Drug classes reported as "Positive" are automatically reflexed to mass spectrometry confirmation/quantitation testing. An immunoassay unconfirmed positive screen result may be useful for medical purposes but does not meet forensic standards.
4. The absence of expected drug(s) and/or drug metabolite(s) may indicate non-compliance, inappropriate timing of specimen collection relative to drug administration, poor drug absorption, or limitations of testing. The concentration at which the screening test can detect a drug or metabolite varies within a drug class. Specimens for which drugs or drug classes are detected by the screen are automatically reflexed to a second, more specific technology (mass spectrometry). The concentration value must be greater than or equal to the cutoff to be reported as positive. Interpretive questions should be directed to the laboratory.
5. For medical purposes only; not valid for forensic use.
Test Performed by: ARUP Laboratories
500 Chipeta Way
Salt Lake City, UT 84108
Day(s) and Time(s) Test Performed Outlines the days and times the test is performed. This field reflects the day and time the sample must be in the testing laboratory to begin the testing process and includes any specimen preparation and processing time required before the test is performed. Some tests are listed as continuously performed, which means assays are performed several times during the day.
Sunday through Saturday
Analytic Time Defines the amount of time it takes the laboratory to setup and perform the test. This is defined in number of days. The shortest interval of time expressed is "same day/1 day," which means the results may be available the same day that the sample is received in the testing laboratory. One day means results are available 1 day after the sample is received in the laboratory.
Maximum Laboratory Time Defines the maximum time from specimen receipt at Mayo Medical Laboratories until the release of the test result
Performing Laboratory Location The location of the laboratory that performs the test
CPT Code Information Provides guidance in determining the appropriate Current Procedural Terminology (CPT) code(s) information for each test or profile. The listed CPT codes reflect Mayo Medical Laboratories interpretation of CPT coding requirements. It is the responsibility of each laboratory to determine correct CPT codes to use for billing.
80101 x 9
82542-Marijuana (if appropriate)
82520-Cocaine (if appropriate)
83925-Opiates (if appropriate)
83992-Phencyclidine (if appropriate)
82145-Amphetamines (if appropriate)
82205-Barbiturates (if appropriate)
80154-Benzodiazepines (if appropriate)
83840-Methadone (if appropriate)
83925-Propoxyphene (if appropriate)
LOINC® Code Information Provides guidance in determining the Logical Observation Identifiers Names and Codes (LOINC) values for the result codes returned for this test or profile.
| Result ID | Reporting Name | LOINC Code |
|---|---|---|
| Z2959 | Amphetamines, S/P | In Process |
| Z3006 | Methamphetamine, S/P | In Process |
| Z2960 | Barbiturates, S/P | In Process |
| Z2961 | Benzodiazepine, S/P | In Process |
| Z2962 | Cannabinoids, S/P | In Process |
| Z2963 | Cocaine, S/P | In Process |
| Z2964 | Methadone, S/P | In Process |
| Z2965 | Opiates, S/P | In Process |
| Z3007 | Oxycodone, S/P | In Process |
| Z2966 | Phencyclidine, S/P | In Process |
| Z2967 | Propoxyphene, S/P | In Process |
| Z2968 | Drug Screen Comments, S/P | In Process |
External
link
PDF
document
Excel
document
Word
document